Drug Shortage Report for TEVA-PRAVASTATIN

Last updated on 2024-11-01 History
Report ID 229948
Drug Identification Number 02247008
Brand name TEVA-PRAVASTATIN
Common or Proper name PRAVASTATIN 10MG TABS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PRAVASTATIN SODIUM
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size PP30
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-06-06
Estimated end date 2024-10-20
Actual end date 2024-10-31
Shortage status Resolved
Updated date 2024-11-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2024-11-01 French Compare
v15 2024-11-01 English Compare
v14 2024-09-19 French Compare
v13 2024-09-19 English Compare
v12 2024-09-12 French Compare
v11 2024-09-12 English Compare
v10 2024-09-05 French Compare
v9 2024-09-05 English Compare
v8 2024-08-08 French Compare
v7 2024-08-08 English Compare
v6 2024-07-18 French Compare
v5 2024-07-18 English Compare
v4 2024-06-27 French Compare
v3 2024-06-27 English Compare
v2 2024-06-07 French Compare
v1 2024-06-07 English Compare

Showing 1 to 16 of 16